Immune checkpoint inhibitor–related colitis in patients on immunotherapy for cancer

Online journal article in Immunology that offers 1.0 continuing education (CME) credit that can be used to fulfill CC Part II requirements.

Quantity:

Want to save more?

Log into see if you qualify for a lower rate.

Members

save $5.00 or more

Intended Audience: Pathologists, Residents, Clinical Scientists, Pathologist Assistants

Upon completion of this activity, you will be able to:

Describe the general mechanism of immune checkpoint inhibitors.
Outline the range of symptoms, endoscopic presentation, and time courses of presentation...

Intended Audience: Pathologists, Residents, Clinical Scientists, Pathologist Assistants

Upon completion of this activity, you will be able to:

Describe the general mechanism of immune checkpoint inhibitors.
Outline the range of symptoms, endoscopic presentation, and time courses of presentation of colitis in patients on immune checkpoint inhibitors.
List the common types of histological changes that can be observed in colonic biopsies from patients being treated with immune checkpoint inhibitors

View More View Less